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BIOACCESSIBILITY AND BIOAVAILABILITY OF ANTIHYPERTENSIVE 
PEPTIDES IN PIGS. 
 
1.- DESCRIPTION OF THE SAMPLES AND BACKGROUND 
 
Lowpept is a functional ingredient commercialised by Innaves S.A. with 
demonstrated antihypertensive properties. This product is obtained by hydrolysis of casein 
Prodiet 85B (77.40% of protein) with a food-grade enzyme subjected to a microfiltration and 
nanofiltration. The hydrolysate had a protein content of 77.47% (w/w), determined by 
Kjeldahl. The peptide composition of Lowpept® has been characterized by liquid 
chromatography coupled on line to tandem mass spectrometry (HPLC-MS/MS). The active 
peptide sequences (RYLGY and AYFYPEL) were quantified by using an external calibration 
curve with the synthetic peptides. The concentrations of these peptides were 2.06 mg/g and 
9.74 mg/g of dry product for RYLGY and AYFYPEL, respectively. 
 
The in vivo antihypertensive activity of Lowpept® has been evaluated in 
spontaneously hypertensive rats. Significant systolic blood pressure decrease was observed 
at 2, 4, 6 and 8 hours upon administration of Lowpept® (Figure 2). Non-hydrolysed casein 
produced no significant decrease of the SBP in the animals. 
 
 
 
Figure 2: Changes in systolic blood pressure after oral administration of the casein hydrolysate 
Lowpept® (300mg/kg body weight) vs administration of water or casein (300mg/kg body weight). Data 
are expressed as mean values ± SEM (n=4-6). Significant differences after administration of the 
casein hydrolysate vs water are indicated at P≤ 0.05(*) and P≤ 0.01 (**). Significant differences after 
administration of casein hydrolysate vs the control of casein were found at P≤ 0.01 (##). 
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2. - OBJECTIVES 
Given the different in vivo physiological effect exerted by these two products, the 
casein hydrolysate and its precursor casein, the objective of this STSM is to obtain some 
knowledge about the resistance and behaviour of peptides in the gastrointestinal tract during 
in vivo digestion in pigs available in Rennes (Host institution), especially of those 
previously identified as antihypertensive peptides. To carry out this general objective, the 
following tasks will be performed in Madrid (Home institution) on the duodenal and plasma 
samples collected from pigs: 
- Exhaustive characterization of the total peptidome of the digestive contents 
obtained after oral administration of casein or its hydrolysate. 
- Specific screening of active regions and derived fragments (by MRM).  
- Kinetics of amino acids in plasma 
- Determine the oral bioavailability of the antihypertensive peptides or derived 
fragments after ingestion of the test meals. 
- Comparison of the peptidome obtained after in vivo digestion and in vitro 
digestion of casein and its hydrolysate. 
 
3. - WORK PLAN 
3.1. In vivo experiments. Animal procedure (Performed during STSM, at host 
Institution) 
The experimental procedure was performed twice; once to collect the duodenal 
effluents and the second one to collect plasma samples, being the days of sampling 
separated by at least 2 days. 
Preparation of test meals: Casein and casein hydrolysate (129 g of powder, containing 100 g 
of protein) were reconstituted in water (250 mL) in order to obtain the same final protein 
content with these two products and to satisfy the protein daily requirements of the animals. 
Chromium-EDTA (2.77 mg/mL Cr) to both samples as marker of the liquid phase, was added 
to reach a final concentration of chromium of 110 ppm, w/w.  
Ingestion of test meals and collection of duodenal effluents: The animals were in first place 
adapted to the meals during several days before the trial day, mixing skimmed milk powder 
with increasing amounts of casein or casein hydrolysate and with the solution of Chromium-
EDTA, which conferred violet colour to the test meal. The trial day the test meal was 
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provided to the pigs for 10 min. Duodenal effluents will be collected 15 min before and 5, 10, 
15, 20, 30, 45 min, 1 h, 1h30, 2h and 2h30 after ingestion of test meal. The sampling was 
stopped when 40 ml were collected or after 3 min of sampling time. A protease inhibitor 
(Pefabloc® at 2.5 mM final concentration) was previously added to the container where the 
sampling was done and kept at 4°C till use. The collected duodenal samples were stored at -
20°C. 
Plasma samples: Blood sampling was performed at 15 min before and 5, 20, 45 min, 1, 2, 3, 
4 and 6 h after ingestion of the casein or its hydrolysate. Blood samples were collected in 
heparinized-lithium tubes where a protease inhibitor cocktail for plasma samples was 
previously added (1 tablet/10 ml blood) (Complete Mini, EDTA-free, Roche). Then, 
centrifugation at 3000  g 4°C for 10 min, was performed and the supernatant was 
introduced into liquid nitrogen and stored at -80°C.  
 
3.2. Duodenal effluents analysis (Home institution, on-going work) 
Chromium analysis 
Freeze-dried duodenal effluents will be used for chromium analysis. The chromium 
content will be determined using an inductively coupled plasma mass spectrometry (ICP-MS) 
instrument  NexION 300XX (Perkin-Elmer). 
Mass spectrometry of duodenal extracts 
Freeze-dried duodenal extract will be re-solubilised in solvent A (water/ formic acid 
0.1%) at a concentration of 3 mg protein/ml water and centrifuged at 8500  g for 10 min 
before being analysed by HPLC-MS/MS. In a separate aliquot, in order to perform 
phosphopeptide determination, an enrichment step by selective precipitation will be carried 
out, by adding CaCl2 and ethanol. The reversed-phase-HPLC-MS/MS analyses of duodenal 
extracts and the enriched samples will be carried out as described by Sánchez-Rivera et al. 
(2014).  
 
3.3. Plasma analysis (Home institution, on-going work) 
Amino acid concentration in plasma 
20 µl of Sulfosalicilic acid (50%) were added to 200µl of plasma. It will be homogenized and 
centrifuged for 15 min at 13000 rpm, and analysed by HPLC.  
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Plasma analysis by mass spectrometry 
Plasma samples from pigs will be prepared as previously described (Sánchez-Rivera 
et al., 2014). Protein precipitation will be carried out by adding acid solution (10 % of TFA) to 
plasma, then, homogenized and heated at 99°C for 2 min, and later on, centrifuged at 8500  
g for 30 min. The supernatant will be purified using solid phase extraction cartridges, and 
dried by vacuum centrifugation. The analyses of samples will be performed on an Acquity 
Ultrahigh Performance Liquid Chromatography (UPLC) coupled to a MicroTof-QII.  
 
3.4. In vitro digestion of casein and its hydrolysate (Home institution, on-going work) 
The samples of casein and its hydrolysate will be subjected to a hydrolysis process 
which simulates gastrointestinal digestion according to the static in vitro model described by 
Minekus et al. (2014) at home institution (Madrid). 
 
4.- RESULTS 
Nitrogen content in duodenal fluids. So far, the duodenal fluids from few pigs have been 
analysed to obtain the nitrogen %, they are shown in the graph below as preliminary results. 
In general, it was observed that the nitrogen values are higher in the samples from pigs fed 
the hydrolysate vs the casein. Probably due to the gastric emptying, which is expected to be 
faster for the corresponding hydrolysate compared with its intact precursor product; in 
agreement with previously reported results (Calbet et al., 2004. Moughan et al.,1991).   
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HPLC-MS/MS analysis of duodenal samples. For the moment, duodenal contents from some 
pigs have been analysed by HPLC-MS/MS, although the identification of peptide sequences 
has not been completed. Below, the total ion chromatogram of duodenal contents from pigs 
fed casein and hydrolysate at 20 min of digestion is shown.  
 
 
 
 
 
 
Amino acid concentration in plasma. So far, plasma samples from few animals have been 
analysed. Overall, after the hydrolysate ingestion the amino acids kinetics in plasma differed 
in comparison with that obtained after ingestion of casein. Higher concentration was 
observed in pigs fed the hydrolysate vs the casein. Furthermore, the major part of these 
amino acids reached their highest concentration in blood earlier after ingestion of the 
hydrolysate vs the casein as seen in some of the graphs below. 
     
 
In addition to the amino acids, some products derived from amino acids and metabolites 
were determined. As an example, the urea and α-aminoadipic acid (derived from lysine 
metabolism) are graphed below. As occurs, for the protein aminoacids, plasma levels for 
most metabolites were higher for the hydrolysate than for the casein, except for β-alanine 
where higher plasma levels were found in pigs fed casein. From the preliminary results 
obtained, no differences are foreseen in the plasma levels of phosphoserine, hydroxyproline, 
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DL-hydroxylysine (produced by hydroxylation of the amino acids proline and lysine, 
respectively) among the animals fed casein and hydrolysate, although statistical analysis will 
be performed when a sufficient number of animals had been analysed.  
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Future collaboration and foreseen publication 
This STSM will give rise to valuable results on in vivo digestion of an antihypertensive 
hydrolysate in pigs which will lead to a publication, and during this internship a solid 
collaboration among both institutions, that will be maintained, was established. 
